关注
Anwar A. Alghamdi
Anwar A. Alghamdi
Assistant Professor
在 kau.edu.sa 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prevalence and nature of medication errors and preventable adverse drug events in paediatric and neonatal intensive care settings: a systematic review
AA Alghamdi, RN Keers, A Sutherland, DM Ashcroft
Drug safety 42, 1423-1436, 2019
1542019
Chemistry and pharmacological actions of delphinidin, a dietary purple pigment in anthocyanidin and anthocyanin forms
A Husain, H Chanana, SA Khan, UM Dhanalekshmi, M Ali, AA Alghamdi, ...
Frontiers in nutrition 9, 746881, 2022
332022
Ameliorative effect of camel's milk and Nigella Sativa oil against thioacetamide-induced hepatorenal damage in rats
A Ahmad, FA Al-Abbasi, S Sadath, SS Ali, MF Abuzinadah, HA Alhadrami, ...
Pharmacognosy magazine 14 (53), 27, 2018
262018
A mixed-methods analysis of medication safety incidents reported in neonatal and children’s intensive care
AA Alghamdi, RN Keers, A Sutherland, A Carson-Stevens, DM Ashcroft
Pediatric Drugs 23, 287-297, 2021
182021
The pattern of reproduction in the Libyan jird (Meriones libycus; Rodentia: Muridae) from central Saudi Arabia in the absence of rainfall
DW Hart, AA Alghamdi, NC Bennett, OB Mohammed, NM Amor, ...
Canadian Journal of Zoology 97 (3), 210-219, 2019
132019
Identification of novel mycobacterium tuberculosis leucyl-tRNA synthetase inhibitor using a knowledge-based computational screening approach
FA Alsulaimany, H Almukadi, NMO Zabermawi, TA Aljuhani, OM Rashidi, ...
Journal of King Saud University-Science 34 (4), 102032, 2022
92022
Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study
AA Alghamdi, RN Keers, A Sutherland, M Hann, J Gray, G Mason, ...
British Journal of Clinical Pharmacology 88 (5), 2213-2222, 2022
62022
Execution time and power consumption optimization in fog computing environment
A Alghamdi, A Alzahrani, V Thayananthan
International journal of computer science and network security: IJCSNS 21 (1 …, 2021
42021
Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A …
M Melaibari, HM Alkreathy, A Esmat, NA Rajeh, RA Shaik, AA Alghamdi, ...
Biomedicines 11 (5), 1342, 2023
32023
The prevalence of irritable bowel syndrome and its co-existence with migraine in medical and non-medical students at Al-Baha university, Saudi Arabia
RH Agwa, Z Alharthi, AT Alzahrani, MA Alghamdi, RA Alzahrani, ...
Cureus 15 (8), 2023
22023
Fog Network Area Management Model for Managing Fog-cloud Resources in IoT Environment
A Alghamdi, A Alzahrani, V Thayananthan
International Journal of Advanced Computer Science and Applications 12 (3), 2021
22021
Triazole: A Potentially Biologically Attractive Scaffold
A Husain, MA Iqbal, O Alam, A Ahmad, SA Khan, AAM Alghamdi
JPMC 2 (2), 149, 2016
22016
Computational Approaches to Evaluate the Acetylcholinesterase Binding Interaction with Taxifolin for the Management of Alzheimer’s Disease
V Ahmad, I Alotibi, AA Alghamdi, A Ahmad, QMS Jamal, S Srivastava
Molecules 29 (3), 674, 2024
12024
Proteomics based systematic exploration of the peptidoglycan biosynthesis of Olsenella uli DSM 7084 towards pathogenesis
MS Akhtar, A Talat, T Bhardwaj, M Alsahag, SB Al-Ghamdi, A Ahmad, ...
2024
The molecular effects of Asperuloside against thermogenesis and anti-inflammatory process through multiple recent obesity pathways: An anti-obesity drug discovery by in-silico …
A Ahmad, A Husain, MF Abuzinadah, AA Alghamdi, V Ahmad, RA Shaik, ...
Journal of King Saud University-Science 35 (8), 102897, 2023
2023
Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management
A Ahmad, AA Alghamdi
Bioinformation 19 (5), 633, 2023
2023
An analysis of medication safety incidents in children's intensive care settings reported to the national reporting and learning system
AA Alghamdi, RN Keers, A Sutherland, A Carson-Stevens, DM Ashcroft
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 6-7, 2021
2021
P0559/# 1814: A MIXED-METHODS ANALYSIS OF MEDICATION SAFETY INCIDENTS REPORTED IN CHILDREN’S INTENSIVE CARE SETTINGS ACROSS ENGLAND AND WALES
A Alghamdi, R Keers, A Sutherland, A Carson-Stevens, D Ashcroft
Pediatric Critical Care Medicine 22 (Supplement 1 3S), 278-279, 2021
2021
P0564/# 1888: INCIDENCE AND NATURE OF ADVERSE DRUG EVENTS IN PAEDIATRIC INTENSIVE CARE UNITS: A PROSPECTIVE MULTICENTRE STUDY
A Alghamdi, R Keers, A Sutherland, J Gray, R Isaac, G Mason, A Manaf, ...
Pediatric Critical Care Medicine 22 (Supplement 1 3S), 280-281, 2021
2021
A Mixed-Methods Analysis of Medication Safety Incidents Reported in Children’s Intensive Care Settings Across England And Wales
AA Alghamdi
Pediatric Critical Care Medicine, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20